Cytokeratin 7 Blocking Peptide for STJ500552 peptide (STJ503853)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 101-151 on human keratin, type II cytoskeletal 7 protein.
General Information
| Short Description | Cytokeratin 7 Blocking Peptide for STJ500552 is synthetically produced from the 101-151 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 101-151 on human keratin, type II cytoskeletal 7 protein. |
| Immunogen Region | 101-151 |
| Specificity | This blocking peptide is recommended for use in combination with Cytokeratin 7 antibody, STJ500552 |
Additional Info
| Background | Serves to block interferon-dependent interphase and stimulates DNA synthesis. Plays a role in the translational regulation of human papillomavirus type 16 E7 mRNA. |
Information sourced from Uniprot.org